Automated system to detect low-grade underlying inflammatory profile: Gaucher disease as a model

被引:30
作者
Rogowski, O
Shapira, I
Zimran, A
Zeltser, D
Elstein, D
Attias, D
Bashkin, A
Berliner, S
机构
[1] Shaare Zedek Med Ctr, Gaucher Clin, IL-91031 Jerusalem, Israel
[2] Shaare Zedek Med Ctr, Dept Med, IL-91031 Jerusalem, Israel
[3] Tel Aviv Univ, Sackler Fac Med, Dept Med D, Tel Aviv Sourasky Med Ctr, IL-69978 Tel Aviv, Israel
关键词
inflammation; Gaucher disease; ESR; fibrinogen; hs-CRP;
D O I
10.1016/j.bcmd.2004.08.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with Gaucher disease, perhaps due to chronic storage of glycolipids, apparently harbor a subclinical or underlying inflammation. Quantification of a baseline inflammatory profile in patients with Gaucher disease is more impressive when compared with that of matched healthy controls in a systematic, automated fashion. A mean of 16 healthy controls was generated for each of 50 patients with Gaucher disease by applying variables relating to potential for inflammatory features, for example, atherothrombotic risk factors. Relative to matched controls, male patients with Gaucher disease had significant elevations in fibrinogen (312 +/- 61 vs. 244 +/- 21 mg/dl; P = 0.002), accelerated erythrocyte sedimentation rate (ESR) (21.5 +/- 16.1 vs. 7.0 +/- 1.4 mm/H; P = 0.004), and elevated high-sensitivity C-reactive protein (hs-CRP) (1.4 +/- 2.4 vs. 0.9 +/- 1.6 mg/l; P = 0.026). Comparison of female patients versus controls revealed significant elevations in fibrinogen (337 +/- 81 vs. 273 +/- 19 mg/dl; P < 0.0005) and accelerated erythrocyte sedimentation rate (33.1 +/- 22.2 vs. 15.6 +/- 3.1 mm/H; P < 0.0005). Enzyme replacement therapy for Gaucher disease did not affect these values. Comparison with the matched healthy controls highlights the true low-grade inflammatory profile in Gaucher disease. By employing information from well-matched controls, even low-grade inflammatory conditions that may have otherwise been considered "within normal limits" can be teased out. This approach is not disease-specific and can be easily applied to any acute or subacute inflammatory disease/condition. (C) 2004 Elsevier Inc. All rights reserved.
引用
收藏
页码:26 / 29
页数:4
相关论文
共 26 条
[1]  
Allen MJ, 1997, QJM-MON J ASSOC PHYS, V90, P19
[2]  
Barak V, 1999, EUR CYTOKINE NETW, V10, P205
[3]   The association between white blood cell count and acute myocardial infarction mortality in patients ≥65 years of age:: Findings from the cooperative cardiovascular project [J].
Barron, HV ;
Harr, SD ;
Radford, MJ ;
Wang, YF ;
Krumholz, HM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2001, 38 (06) :1654-1661
[4]  
Beutler E., 2001, METABOLIC MOL BASES, V3, P3635
[5]  
CLAUSS A., 1957, ACTA HAEMATOL, V17, P237
[6]  
COHEN S, 2003, J INF TECHNOL HEALTH, V1, P195
[7]   Erythrocyte sedimentation rate: a possible marker of atherosclerosis and a strong predictor of coronary heart disease mortality [J].
Erikssen, G ;
Liestol, K ;
Bjornholt, JV ;
Stormorken, H ;
Thaulow, E ;
Erikssen, J .
EUROPEAN HEART JOURNAL, 2000, 21 (19) :1614-1620
[8]   Independent association of various smoking characteristics with markers of systemic inflammation in men -: Results from a representative sample of the general population (MONICA Augsburg Survey 1994/95) [J].
Fröhlich, M ;
Sund, M ;
Löwel, H ;
Imhof, A ;
Hoffmeister, A ;
Koenig, W .
EUROPEAN HEART JOURNAL, 2003, 24 (14) :1365-1372
[9]   Mechanisms of disease: Acute-phase proteins and other systemic responses to inflammation [J].
Gabay, C ;
Kushner, I .
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (06) :448-454
[10]   Emerging risk factors for atherosclerotic vascular disease - A critical review of the evidence [J].
Hackam, DG ;
Anand, SS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (07) :932-940